MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 4, 2006; DOI: 10.1124/mol.105.021998


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.021998v1
70/1/71    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jassen, A. K.
Right arrow Articles by Madras, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jassen, A. K.
Right arrow Articles by Madras, B. K.


Received for publication January 3, 2006.
Revised April 3, 2006.
Accepted for publication April 4, 2006.

RECEPTOR REGULATION OF AXON GUIDANCE MOLECULE GENE EXPRESSION

Amy K. Jassen 1, Hong Yang 2, Gregory M Miller 2, Elizabeth Calder 3, Bertha K. Madras 3*

1 Harvard Medical School,New England Primate Research Center 2 Harvard Medical School, New England Primate Research Center 3 Harvard Medical School/New England Primate Research Center

* Address correspondence to: E-mail: bertha_madras{at}hms.harvard.edu

Abstract

Axon guidance molecules, critical for neurodevelopment, are also implicated in morphological and other neurodaptative changes mediated by physiological or pharmacological events in adult brain. As an example, the psychostimulant cocaine markedly alters axon guidance molecules in adult brain of cocaine-treated rats. To decipher a potential link between drug-induced activation of G-protein coupled receptors (GPCRs) and modulation of axon guidance molecules, we investigated whether GPCR activity in a SK-N-MC human neuroepithelioma cell line (which expresses low levels of D1 dopamine receptors) affects gene expression of axon guidance molecules (semaphorins, ephrins, netrins and their receptors). Using real time PCR, we identified 17 of 26 axon guidance molecules in these cells, with varying levels of expression. Forskolin, which raised intracellular cAMP levels 340%, increased EphA5, EphB2 and Neuropilin1 expression, paralleling reported changes in the rat hippocampus after cocaine treatment. The dopamine receptor agonist dihydrexidine, which raised cAMP levels 22%, promoted regulatory changes in EphrinA1, EphrinA5, EphB1, DCC and Semaphorin3C, whereas SKF 81297 altered EphA5, EphrinA1 EphrinA5 and neuropilin1. cAMP and other signal transduction pathways may regulate axon guidance molecule gene expression, potentially linking monoamine receptor activation to signal transduction cascades, transcriptional regulation of axon guidance molecules and alterations in neural networks.


Key words: Dopamine, cAMP, CREB, Regulation of gene expression, Cocaine, Synaptic plasticity


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Iwakura, H. Nawa, I. Sora, and M. V. Chao
Dopamine D1 Receptor-induced Signaling through TrkB Receptors in Striatal Neurons
J. Biol. Chem., June 6, 2008; 283(23): 15799 - 15806.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhang, A. Vinuela, M. H. Neely, P. J. Hallett, S. G. N. Grant, G. M. Miller, O. Isacson, M. G. Caron, and W.-D. Yao
Inhibition of the Dopamine D1 Receptor Signaling by PSD-95
J. Biol. Chem., May 25, 2007; 282(21): 15778 - 15789.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Xie, S. V. Westmoreland, M. E. Bahn, G.-L. Chen, H. Yang, E. J. Vallender, W.-D. Yao, B. K. Madras, and G. M. Miller
Rhesus Monkey Trace Amine-Associated Receptor 1 Signaling: Enhancement by Monoamine Transporters and Attenuation by the D2 Autoreceptor in Vitro
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 116 - 127.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics